|
Keith is a scientist and entrepreneur in the for profit and non profit biomedical space. He was a co-founder and the Executive Director of the i2b2/tranSMART Foundation, a 501c3 non profit open-source, open-data foundation focused on realizing the promise of precision medicine. Keith cofounded the tranSMART Foundation, was its CEO from 2013-2017, and managed its merger with the i2b2 Foundation. Previously he was the VP of Systems Biology at CHDI (a Huntington's disease foundation), where he oversaw a budget of $60M, and implemented a systems biology-based preclinical drug discovery program. Keith spent 12 years in the Pharmaceutical industry with Merck and Bayer, and another 10 years in the Biotech industry as CSO of Gene Logic, and CEO of Viaken and Genstruct/Selventa. he has been the Founder and CEO/Executive Chairman of several new startup companies in the areas of biomedical computing and artificial intelligence (Axiomedix, Ingentium, PSertain Technologies, etc.), and has served as an advisor to numerous venture capital firms, including Atlas Ventures, Oak Investment Partners and Flagship Ventures, as well as leading biotech, healthcare and AI companies.
|
OSPF is a supporter of the Open Source Pharma Movement and Community
|
|